Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05946616
Other study ID # 00126392
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2023
Est. completion date March 31, 2024

Study information

Verified date July 2023
Source Medical University of South Carolina
Contact Kirstin-Friederike Heise, PhD
Phone (843)792-
Email heisek@musc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sometimes, it is necessary to re-learn a previously learned movement behavior, for example, a bad posture during the golf drive or while playing the piano. Unlearning or relearning an intensively trained behavior is particularly important if the behavior is hampering recovery, for example, in chronic pain or after a stroke. With this pilot study, the brain mechanisms that control the change of pre-existing stable memories of a motor skill will be tested with electroencephalography (EEG). Non-invasive brain stimulation will be used to modulate these brain mechanisms and test if it is possible to change the pre-existing motor memory and the learning of a new motor skill.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date March 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older (2/3 of the final sample will be =60years of age) - No previous stroke, brain tumor, neurodegenerative disease, or trauma to the head - Ability to give consent for study participation - who have access to a personal computer with internet Exclusion Criteria: - • Pregnancy - Inability to use all ten fingers to type on a standard computer keyboard - Uncorrected vision, hindering perception of visual cues presented on a standard computer screen - Medication use at the time of study that may interfere with learning or the effect of tACS, including but not limited to carbamazepine, flunarizine, sulpiride, rivastigmine, dextromethorphan; - Neuromuscular disorders affecting hand and finger movements necessary for 10-finger keyboard typing - Presence of neurological or psychiatric disorders - Presence of scalp injury or disease - Prior history of seizures - Prior intracranial surgery - Prior brain radiotherapy - Prior history of intracranial tumor, intracranial infection, or cerebrovascular malformation - Metal in head or neck - Contraindications to MRI (such as severe claustrophobia, implanted medical devices)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Transcranial alternating current stimulation (tACS) combined with behavioral intervention
Transcranial alternating current stimulation (tACS) combined with behavioral intervention (memory interference).
Inactive (sham) stimulation combined with behavioral intervention
Inactive (sham) stimulation combined with behavioral intervention (memory interference)

Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina

Sponsors (1)

Lead Sponsor Collaborator
Medical University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Behavioral: interference rate Change in performance precision of a previously learned sensorimotor skill before - after one single intervention (1 hour)
Primary Neural: brain connectivity change Change in EEG-derived markers of brain activation and connectivity before - after one single intervention (1 hour)
Secondary Behavioral: interference rate Change in performance precision of a previously learned sensorimotor skill before - after one single intervention (24 hour follow-up)
Secondary Neural: brain connectivity change Change in EEG-derived markers of brain activation and connectivity before - after one single intervention (24 hour follow-up)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1